Cencora, Inc. (LON:0HF3)
336.46
-0.54 (-0.16%)
Dec 5, 2025, 5:02 PM BST
Cencora Revenue
In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B USD with 9.31% growth. Cencora had revenue of $83.73B in the quarter ending September 30, 2025, with 5.92% growth.
Revenue
$321.33B
Revenue Growth
+9.31%
P/S Ratio
0.21
Revenue / Employee
$6.30M
Employees
51,000
Market Cap
49.46B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Cencora News
- 2 days ago - Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities - Business Wire
- 3 days ago - Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 4 weeks ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters
- 4 weeks ago - Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - WSJ
- 4 weeks ago - Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network - Business Wire